Eisler Capital (Us) LLC Abbott Laboratories Call Options Transaction History

Eisler Capital (Us) LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $3.84 Million - $4.54 Million	-38,400 Reduced 24.76%	116,700 $13.3 Billion
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $9.6 Million - $10.7 Million	95,300 Added 159.36%	155,100 $16.1 Billion
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $2.28 Million - $2.52 Million	20,800 Added 53.33%	59,800 $6.8 Billion
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $1.58 Million - $1.93 Million	-17,509 Reduced 30.98%	39,000 $4.29 Billion
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $6.64 Million - $7.97 Million	-69,491 Reduced 55.15%	56,509 $5.47 Billion
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $12.7 Million - $14.1 Million	126,000 New	126,000 $13.7 Billion

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Eisler Capital (Us) LLC, based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Us) LLC with notifications on news.